Titan Bio-Tech Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth from ₹34.75 crore to ₹43.43 crore indicates strong market demand.
Operating profit margin improved to 20.67%, showcasing effective cost management.
Net profit rose to ₹6.52 crore in the latest quarter, reflecting overall financial health.

NEGATIVES

Net profit declined to ₹4.39 crore in Q4, indicating a potential seasonal weakness.
Revenue dipped to ₹39.89 crore in Q3, suggesting volatility in sales.
Operating profit margin decreased to 9.19% in Q4, raising concerns about profitability.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	43.43	45.98	39.92	43.11	39.89	38.28	35.17	46.50
Expenses	35.85	36.48	34.02	36.22	33.49	34.76	31.52	39.11
Operating Profit	7.57	9.50	5.90	6.89	6.40	3.52	3.65	7.39
Other Income	0.55	0.44	0.48	0.62	0.32	1.59	1.38	0.72
Interest	0.28	0.26	0.34	0.31	0.27	0.15	0.08	0.20
Depreciation	0.86	0.83	0.84	1.05	1.10	1.18	0.84	1.15
Profit Before Tax	8.62	9.73	6.53	8.22	8.41	5.69	5.31	8.81
Tax	2.10	2.56	1.53	1.82	1.71	1.30	1.26	1.95
Net Profit	6.52	7.17	5	6.40	6.70	4.39	4.05	6.86
Eps in Rs	7.89	8.68	6.05	7.74	8.10	5.31	4.90	8.30